 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$131.78 |
$135.18 |
$131.49 |
$132.99 |
1.03M | | 04/17/2024 |
$133.11 |
$134.44 |
$131.36 |
$133.23 |
571.10K | | 04/18/2024 |
$133.23 |
$134.20 |
$131.00 |
$132.54 |
586.50K | | 04/19/2024 |
$132.65 |
$133.65 |
$130.13 |
$132.00 |
556.30K | | 04/22/2024 |
$132.48 |
$134.18 |
$131.79 |
$133.66 |
575.10K |
|
|
| Neurocrine Biosciences is applying its capabilities into neuroscience to develop medicines for neurology, neuroendocrinology and neuropsychiatry-related disorders and diseases. Co.'s commercially available medicines include INGREZZA®, which provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 mg, 60 mg and 80 mg capsules); and ONGENTYS®, which is a once-daily, peripherally acting Catechol-O-methyltransferase inhibitor utilized to prolong the duration of effect of levodopa, the primary treatment option for Parkinson's disease patients, during periods of the day where the effects of levodopa wear off and motor symptoms worsen. | |
|
Neurocrine Biosciences (NBIX) has the following price history information. Looking back at NBIX historical stock prices for the last five trading days, on April 16, 2024, NBIX opened at $131.78, traded as high as $135.18 and as low as $131.49, and closed at $132.99. Trading volume was a total of 1.03M shares. On April 17, 2024, NBIX opened at $133.11, traded as high as $134.44 and as low as $131.36, and closed at $133.23. Trading volume was a total of 571.10K shares. On April 18, 2024, NBIX opened at $133.23, traded as high as $134.20 and as low as $131.00, and closed at $132.54. Trading volume was a total of 586.50K shares. On April 19, 2024, NBIX opened at $132.65, traded as high as $133.65 and as low as $130.13, and closed at $132.00. Trading volume was a total of 556.30K shares. On April 22, 2024, NBIX opened at $132.48, traded as high as $134.18 and as low as $131.79, and closed at $133.66. Trading volume was a total of 575.10K shares.
NBIX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Neurocrine Biosciences shares, starting with a $10,000 purchase of NBIX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$13.79 |
|
| End price/share: |
$133.66 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
869.25% |
|
| Average Annual Total Return: |
25.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$96,908.38 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/16/2024 | $132.99 | | 04/17/2024 | $133.23 | | 04/18/2024 | $132.54 | | 04/19/2024 | $132.00 | | 04/22/2024 | $133.66 |
|
|
Free NBIX Email Alerts:
